Atypical antipsychotic-like effects of the dopamine D 3 receptor agonist, (+)-PD 128,907

By Witkin J.   Gasior M.   Acri J.   Beekman M.   Thurkauf A.   Yuan J.   DeBoer P.   Wikstrom H.   Dijkstra D.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Autoradiographic comparison of D 2 - and D 3 -dopamine receptor localization in the post mortem human brain using [ 125 I]epidepride and [ 3 H]PD 128907

By Hall H.   Halldin C.   Suzuki M.   Dijkstra D.   Wikstrouml m H.   Wise L.D.   Pugsley T.A.   Hurd Y.   Farde L.   Pauli S.   Sedvall G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 346-346

Elsevier

Access to resources Recommend Favorite

Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders

By  

Current Pharmaceutical Design, Vol. 9, Iss. 8, 2003-03 ,pp. : 643-671

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine D 2 receptors play a role in the (-)-apomorphine-like discriminative stimulus effects of (+)-PD 128907

By Kleven M.S.   Koek W.  

European Journal of Pharmacology, Vol. 321, Iss. 1, 1997-02 ,pp. : 1-4

Elsevier

Access to resources Recommend Favorite

Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics

By  

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3700-3724

Bentham Science Publishers

Access to resources Recommend Favorite